CR2 and B-cell chronic lymphocytic leukemia: When focused on CLL susceptibility, reduced CD21 expression has been reported on CLL B cells (particularly in unmutated IGHV CLL) and has also correlated with disease stage and poor prognosis (Nichols et al., 2015).